Background: Despite that stakeholder participation in evidence synthesis could result in more useful outcomes, there are few examples of processes that actively involve them in synthesis work. Techniques are needed that engage diverse stakeholders as equal partners in knowledge co-production. The aims of this paper are to describe an innovative participatory process of synthesising a large body of academic research products and compare the findings of the participatory process against two traditional approaches to synthesis: a rapid review and a structured review. Methods: First, a rapid synthesis of all research outputs (n = 86) was conducted by researchers with in-depth knowledge of the collaboration’s research. Second, a team of researchers and service providers conducted a structured synthesis of seventy-eight peer-reviewed articles and reports generated by the collaboration. Fifty-five publications were brought forward for further synthesis in part three, a facilitated participa
Customized Nanoparticles and Rapid Synthesis of New Nanoparticle Compositions
Written by AZoNanoJul 19 2013
Avantama’s range of products includes simple or complex oxide nanoparticles, advanced metal salt nanoparticles or doped nanoparticles (metal oxide and metal salt nanoparticles) which are produced according to individual specifications and in any composition. It is possible to order the desired compositions on their web shop in a fast and efficient way. Each customer can define the exact composition he desires and order the samples online.
Avantama nanoparticles are typically 10 to 50nm in size, and are characterized by extraordinary stability and chemical purity. Typical examples are applications such as antimicrobials, lasers and catalysts. The crystal phase of compositions can be adapted in many cases. If required, the Avantama nanoparticles can also be formulated into a nanoparticles ink, suspension or dispersion.
New Method Tests Vaccine Strategies Against Novel Pathogens by Angela Mohan on January 19, 2021 at 11:00 AM
Protein-based immunization method developed by the Australian researchers, can be used to test various vaccine strategies against novel pandemic pathogens including SARS-CoV-2.
The research was led by Professor Richard Payne at the University of Sydney and Professor Warwick Britton at the Centenary Institute. The team has demonstrated application of the method with a new vaccine for use against tuberculosis (TB), which has generated a powerful protective immune response in mice.
Researchers want to identify vaccine strategy to assist in the rapid pre-clinical testing of new vaccines, particularly for respiratory illnesses.